JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mohammad Hossein Mandegar
Mohammad Ali Yousefnia
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandegar, M. H.
Right arrow Articles by Alaeddini, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mandegar, M. H.
Right arrow Articles by Alaeddini, F.
Related Collections
Right arrow Coronary disease

J Thorac Cardiovasc Surg 2008;136:930-936
© 2008 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: Left ventricular volume and amount of viable myocardium

Mohammad Hossein Mandegar, MD, Mohammad Ali Yousefnia, MD, Farideh Roshanali, MD*, Hussein Rayatzadeh, MD, Farshid Alaeddini, MD, PhD

Day General Hospital, Tehran, Iran

Received for publication July 4, 2007; revisions received September 3, 2007; accepted for publication November 1, 2007.

* Address for reprints: Farideh Roshanali, MD, N0.1, 8th Floor, 15th Tower, Hormozan St, Ghods Shahrak, Tehran, 14466, Iran. (Email: farideh_roshanali{at}yahoo.com).

Objective: In patients with ischemic cardiomyopathy and substantial amounts of dysfunctional but viable myocardium, revascularization cannot always improve the left ventricular ejection fraction. We sought to investigate the interaction between the left ventricular volume and the amount of viable myocardium to predict the left ventricular ejection fraction increase after revascularization.

Methods: Eighty-five consecutive patients with a depressed left ventricular ejection fraction (mean: 27.3% ± 5.2%) underwent coronary artery bypass grafting after a dobutamine stress echocardiography had determined that they had at least 4 viable segments. Six months after coronary artery bypass grafting, left ventricular ejection fraction and regional wall motion were reassessed.

Results: Although the left ventricular ejection fraction was expected to recover more than 5% in all 85 patients after coronary artery bypass grafting, it did not improve in 15 patients (17.6%) despite the presence of viable segments. The likelihood of the left ventricular ejection fraction recovery decreased proportionally with an increase in the left ventricular end-systolic volume. The nonimprovers had a higher left ventricular end-systolic volume (164.2 ± 22.4 mL vs 125.6 ± 23.4 mL, P = .0001). In addition, the number of viable segments during the dobutamine stress echocardiography had a significant correlation with the ejection fraction increase after 6 months (P < .0001). Patients with 6 viable segments showed a good outcome irrespective of their left ventricular end-systolic volume. In patients with fewer than 6 viable segments, left ventricular end-systolic volume was a major factor in the prognosis: Patients with left ventricular end-systolic volume of 145 or more had a poor left ventricular ejection fraction increase and vice versa.

Conclusion: The extent of left ventricular remodeling determines the rate of functional improvement after coronary artery bypass grafting. Patients with a high left ventricular end-systolic volume and fewer than 6 viable segments have a lower likelihood of improvement.



Abbreviations and Acronyms CABG = coronary artery bypass grafting; DSE = dobutamine stress echocardiography; EF = ejection fraction; LV = left ventricular; LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVESVI = left ventricular end-systolic volume index








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.